The long-term survival after lung transplantation (LT) is favorable in Japan. However, long-
term survivors after LT are subject to late complications, including chronic lung allograft …

The diagnosis and management of chronic lung allograft dysfu... : Current Opinion in Pulmonary
Medicine The diagnosis and management of chronic lung allograft dysfunction : Current …

Background. Bronchiolitis obliterans syndrome (BOS) after lung transplantation is
characterized by fibrotic small airway remodeling, recognizable on high-resolution …

Background Chronic lung allograft dysfunction (CLAD) is the major cause of death post-lung
transplantation, with acute cellular rejection (ACR) being the biggest contributing risk factor …

Abstract The Lung Session of the 2022 16th Banff Foundation for Allograft Pathology
Conference—held in Banff, Alberta—focused on non-rejection lung allograft pathology and …

Introduction The percentage of low attenuation area (% LAA) on computed tomography (CT)
is useful for evaluating lung emphysema, and higher% LAA was observed in patients with …

Rationale: Chronic lung allograft dysfunction (CLAD) is the leading cause of death following
lung transplant, and azithromycin has variable efficacy in CLAD. The lung microbiome is a …

Purpose This study aimed to clarify the effect of donor and recipient age combinations on the
short-term survival rates of patients undergoing lung transplantation. Patients and methods …

Bronchiolitis Obliterans Syndrome (BOS), a fibrotic airway disease following lung
transplantation, conventionally relies on pulmonary function tests (PFTs) for diagnosis due to …

Chronic lung allograft dysfunction (CLAD) remains a major hurdle impairing lung transplant
outcome. Parallel to the better clinical identification and characterization of CLAD and CLAD …